A promising medication, the drug , is generating significant attention within the healthcare community as a anticipated approach for weight challenges. Designed by Eli Lilly , it’s a double GIP and GLP-1 receptor agonist, meaning it operates on two separate pathways to influence hunger and suppor… Read More